Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors

  • Poster presentation: Purpose of the study To compare the lipometabolic profiles of three double-boosted protease inhibitor (PI) regimens at standard dose, containing saquinavir and ritonavir in combination with lopinavir (LOPSAQ), atazanavir (ATSAQ) or fosamprenavir (FOSAQ) in HIV-positive patients, treated without reverse transcriptase inhibitors (RTI). ...

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Annette Wendig, Christoph StephanORCiDGND, Pavel Khaykin, Markus Bickel, Tessa Lennemann, Gaby Knecht, Thomas Lutz, Nils von HentigORCiDGND, Schlomo Staszewski
URN:urn:nbn:de:hebis:30-70666
DOI:https://doi.org/10.1186/1758-2652-11-S1-P122
ISSN:1758-2652
Parent Title (English):Journal of the International AIDS Society
Publisher:Springer
Place of publication:Berlin ; Heidelberg
Document Type:Article
Language:English
Date of Publication (online):2009/09/20
Date of first Publication:2008/11/10
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
Release Date:2009/09/20
Volume:11
Issue:(Suppl 1):P122
Page Number:2
First Page:1
Last Page:2
Note:
© 2008 Wendig et al; licensee BioMed Central Ltd.
Source:Journal of the International AIDS Society 2008, 11(Suppl 1):P122 ; doi:10.1186/1758-2652-11-S1-P122 ; from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
HeBIS-PPN:218869576
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):License LogoDeutsches Urheberrecht